We are delighted to announce that Professor Anil Koul, London School of Hygiene and Tropical Medicine, U. of London (UK), will be speaking at the 2nd International Virtual Conference on Frontiers in TB & Mycobacteriology, taking place online (Eastern Time, USA) on March 2–3, 2026.
Prof. Koul is an internationally recognized leader in tuberculosis drug discovery and translational research. His recent work focuses on advancing next-generation therapeutics for drug-resistant TB, including efforts to characterize novel mechanisms of action, improve treatment durability, and accelerate the development of innovative antimicrobial agents.
His talk on JNJ6640, a promising next-generation antibiotic building on the success of Bedaquiline to address drug-resistant TB, will provide valuable insights into the future of TB therapy.
Join us virtually to hear from global experts driving innovation in TB science.
Date: March 2–3, 2026
Time / zone: 8am – 3:30pm /eastern time, USA
This conference is organized by Impact Research Communications (IRC)
More info: https://tb.ircconferences.net/ | Frontiers in TB & Mycobacteriology
